Literature DB >> 11458331

High-performance liquid chromatography determination of hydrastine and berberine in dietary supplements containing goldenseal.

E A Abourashed1, I A Khan.   

Abstract

Goldenseal (Hydrastis canadensis L., Ranunculaceae) is an ingredient of various dietary supplements intended for enhancing general body immunity. Many goldenseal products are currently available in the United States, either alone or in combination with echinacea. In most products, the content of the main active alkaloids of goldenseal, hydrastine and berberine, is not indicated on the label. A high-performance liquid chromatography (HPLC) method has been developed for the detection and quantification of hydrastine and berberine in a number of products obtained from the United States market. The method uses a Phenomenex Luna C(18) column, a mobile phase consisting of solvent A (100 mM sodium acetate/acetic acid, pH 4.0) and solvent B (acetonitrile/methanol; 90/10, v/v). Elution was run at a flow rate of 1.0 mL/min, with a linear gradient of 80- 40% A in B over 20 min and ultraviolet detection at 290 nm. A wide range of content variation was observed for both alkaloids in the tested samples.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458331     DOI: 10.1002/jps.1035

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  API determination by NIR spectroscopy across pharmaceutical production process.

Authors:  M Blanco; M Bautista; M Alcalà
Journal:  AAPS PharmSciTech       Date:  2008-11-14       Impact factor: 3.246

2.  An ex vivo approach to botanical-drug interactions: a proof of concept study.

Authors:  Xinwen Wang; Hao-Jie Zhu; Juliana Munoz; Bill J Gurley; John S Markowitz
Journal:  J Ethnopharmacol       Date:  2015-01-24       Impact factor: 4.360

3.  In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.

Authors:  Bill J Gurley; Stephanie F Gardner; Martha A Hubbard; D Keith Williams; W Brooks Gentry; Ikhlas A Khan; Amit Shah
Journal:  Clin Pharmacol Ther       Date:  2005-05       Impact factor: 6.875

4.  CYP2D plays a major role in berberine metabolism in liver of mice and humans.

Authors:  Ying Guo; Feng Li; Xiaochao Ma; Xingguo Cheng; Honghao Zhou; Curtis D Klaassen
Journal:  Xenobiotica       Date:  2011-07-25       Impact factor: 1.908

5.  Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.

Authors:  Bill J Gurley; Ashley Swain; Gary W Barone; D Keith Williams; Philip Breen; C Ryan Yates; Leslie B Stuart; Martha A Hubbard; Yudong Tong; Sreekhar Cheboyina
Journal:  Drug Metab Dispos       Date:  2006-11-01       Impact factor: 3.922

6.  Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.

Authors:  Bill J Gurley; Ashley Swain; Martha A Hubbard; D Keith Williams; Gary Barone; Faith Hartsfield; Yudong Tong; Danielle J Carrier; Shreekar Cheboyina; Sunil K Battu
Journal:  Mol Nutr Food Res       Date:  2008-07       Impact factor: 5.914

Review 7.  Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach.

Authors:  Joshua J Kellogg; Mary F Paine; Jeannine S McCune; Nicholas H Oberlies; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-08-14       Impact factor: 13.423

8.  Determination of hydrastine and berberine in goldenseal raw materials, extracts, and dietary supplements by high-performance liquid chromatography with UV: collaborative study.

Authors:  Paula N Brown; Mark C Roman
Journal:  J AOAC Int       Date:  2008 Jul-Aug       Impact factor: 2.028

Review 9.  Chemical Authentication of Botanical Ingredients: A Review of Commercial Herbal Products.

Authors:  Mihael Cristin Ichim; Anthony Booker
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.